# Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease

> **NCT03038334** · NA · UNKNOWN · sponsor: **Metabolic Therapy Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Magnesium sulfate

## Key facts

- **NCT ID:** NCT03038334
- **Lead sponsor:** Metabolic Therapy Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-20
- **Primary completion:** 2019-08-20
- **Final completion:** 2019-10-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038334, "Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03038334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*